The feasibility of utilizing vapor-phase hydrogen peroxide (VPHP) as a surface decontaminant and sterilant was evaluated in a centrifuge application. The prototype VPHP decontamination system, retrofitted into a Beckman L8-M ultracentrifuge, was designed to vaporize a 30% (wt/wt) solution of aqueous hydrogen peroxide continuously injecting and withdrawing VPHP in a deep-vacuum flow-through system. VPHP cycles of 4, 8, 16, and 32 min were examined for cidal activity against spores of Bacillus subtilis subsp. globigii and Bacillus stearothermophilus. Spore inocula (_ 106/coupon) were dried onto 0.5-in. (1.27-cm)-square stainless-steel coupons, and coupons were suspended in the centrifuge chamber, the space between the refrigeration can and the barrier ring (inner gap), and the space between the barrier ring and the vacuum ring (outer gap). At a chamber temperature of 4°C, B. subtilis subsp. globigii spores were inactivated within 8 min, while inactivation of spores located in the outer gap at 27°C required 32 min. The elevated temperature and high surface area/volume ratios in the outer gap may serve to decompose the gas more rapidly, thus reducing cidal efficacy. Of the two test spores, B. stearothermophilus was more resistant to VPHP. Nonetheless, VPHP was shown to possess significant sporicidal capability. For practical decontamination applications of the type described, VPHP shows promise as an effective and safer alternative to currently used ethylene oxide or formaldehyde vapors.
The germicidal properties of aqueous hydrogen peroxide (H202) have been recognized for more than a century. The literature contains numerous accounts of the satisfactory application of H202 as a disinfectant for inanimate materials and inert surfaces free of inactivating levels of catalase. In addition to bactericidal and virucidal properties, H202 in relatively high concentrations (10 to 30%) appears to be a good sporicide (11, 15) . Hydrogen peroxide solutions have been recommended for the disinfection of surgical implant components (6) , temperature-sensitive plastic equipment (17) , spacecraft hardware (20) , hydrophilic soft contact lenses (7, 16) , commercial packing materials (10, 12) , water (9, 21) , and milk (8) . Toledo (13) suggests that H202 shows great promise as an in-line sterilant for aseptic packaging of fluid foods. Recent studies have also concentrated on enhancing the germicidal properties of H2O, by synergistic application with ultrasonic waves (1) or UV light (2, 18) . A combined application of H,02 with UV irradiation may be especially well suited for the surface sterilization of packaging materials prior to filling them with ultra-high-temperature-processed products (18) .
While aqueous hydrogen peroxide has a long history of use as a sterilant, the concept of vapor-phase H202 (VPHP) sterilization has been developed within the past decade. VPHP represents a class of nontoxic cold gas sterilant which provides an opportunity to discontinue the use of such The composite results of trials in which coupons inoculated with B. subtilis subsp. globigii spores were subjected to various VPHP cycles are presented in Table 1 . These data indicate that VPHP cycles of 8 min or more appear capable of sterilizing the centrifuge chamber. Sterilization of the centrifuge inner and outer gaps appears to be more difficult to achieve. A great many of the inner and outer gap coupons which remained contaminated were located at the positions most distant from the outer gap injection port. The observed pattern may be related to VPHP dispersion inefficiency or VPHP decomposition as VPHP diffuses to distant locations in the centrifuge gaps or to both. Nonetheless, the data show a trend toward increased decontamination in both gaps with longer VPHP cycles. Table 3 . The data clearly show that, of the two test spores, B. stearothermophilus is significantly more resistant to VPHP under the exposure conditions contained within the prototype centrifuge unit.
DISCUSSION
In laboratory practice, the decontamination of centrifuges has historically presented a difficult challenge. Spill problems encountered can range from leakage due to minor chips or cracks in tubes or overfilling of tubes to catastrophic rotor failure. Since spills often involve high concentrations of pathogenic organisms, the procedure used must adequately decontaminate the readily accessible rotor chamber area of the centrifuge while protecting the personnel performing the spill cleanup. In addition, for a spill occurring in a centrifuge operating under a vacuum, the potential contamination of the less accessible gaps and pumps must be addressed. While liquid disinfectants are of limited value for reaching inaccessible areas, vapor-phase germicides offer obvious penetration advantages. Formaldehyde and ethylene oxide, the vapors commonly used for centrifuge decontamination, require extended exposure times to achieve sterilization and are toxic or carcinogenic. Conversely, VPHP provides rapid inactivation rates and decomposes to water vapor and oxygen.
The results of this study indicate that VPHP has considerable potential for use in a centrifuge decontamination application. In the centrifuge chamber, spore inocula dried onto stainless-steel coupons (_106 spores per coupon) were consistently killed within 8 min. This implies that VPHP cycle times of this magnitude, used for routine decontamination at the conclusion of an experiment or the end of a workday, could be depended upon to protect laboratory personnel. A longer cycle time (-32 min) appears desirable to achieve an adequate margin of safety following an obvious spill (tube breakage) or to assure decontamination of less accessible areas prior to servicing the centrifuge unit. In addition, VPHP was shown to be an effective decontaminant when applied at low temperatures. A temperature profile of the centrifuge (Fig. 1) indicates that the inner and outer gaps are near room temperature (19°C for the inner gap and 27°C for the outer gap), while the rotor is at 4°C. For both test spores, consistent and significantly greater kill was achieved in the chamber as opposed to the gap areas. This suggests that the low temperature served to keep the VPHP from decomposing before it had time to diffuse throughout the area and inactivate the spores, whereas the higher tempera- 56, 1990 on November 6, 2017 by guest http://aem.asm.org/ Downloaded from tures promoted more rapid decomposition of the gas. Also, the comparatively higher surface area/volume ratio in the gaps may contribute to more rapid vapor decomposition in these locations. Engineering modifications of the prototype unit might resolve these apparent distribution differences and enhance the sporicidal activity of VPHP in the inner and outer gaps of the centrifuge.
The traditional biological indicator of choice for gaseous sterilants is B. subtilis subsp. globigii (3) . In their pioneering evaluation of VPHP sterilization of polyethylene flexible packaging materials used in aseptic systems, Wang and Toledo (19) globigii. An explanation for the observed resistance phenomenon is currently unavailable. The application of VPHP as a potential sterilant is clearly still in its infancy; definitive knowledge of the mechanism(s) of cidal action, and the factors which influence it, is lacking.
The bacterial spore is generally considered to be the most chemical germicide-resistant form of microbial life. As a surface decontaminant used in a centrifuge application, VPHP has been shown to possess significant sporicidal capability. Thus, for laboratory activities involving centrifugation of microorganisms, it is reasonable to presume that 8-to 32-minute decontamination cycles using VPHP will render the centrifuge safe for human exposure. Furthermore, VPHP, with its major advantage of innocuous breakdown products, has significant potential as a high-level disinfectant and chemosterilant for numerous decontamination applications, and further development of such applications should be encouraged.
